PAHC — Phibro Animal Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual income statement for Phibro Animal Health, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	833	942	978	1,018	1,296
Cost of Revenue
Gross Profit	271	285	298	314	409
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	758	863	906	964	1,186
Operating Profit	74.9	79	71.8	53.3	110
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	66.5	72.3	54.1	10.9	68
Provision for Income Taxes
Net Income After Taxes	54.4	49.2	32.6	2.42	48.3
Net Income Before Extraordinary Items
Net Income	54.4	49.2	32.6	2.42	48.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	54.4	49.2	32.6	2.42	48.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.34	1.22	0.908	0.401	1.66
Dividends per Share